Global CMO/CDMO Market Size, Status and Forecast 2022

At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro

Market Analysis and Insights: Global CMO/CDMO Market
In 2021, the global CMO/CDMO market size will be US$ million and it is expected to reach US$ million by the end of 2027, with a CAGR of % during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CMO/CDMO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CMO/CDMO market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CMO/CDMO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CMO/CDMO market.

Global CMO/CDMO Scope and Market Size
CMO/CDMO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CMO/CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.


Segment by Type
Development
API production
Formulation


Segment by Application
Pharmaceutical Industry
Biotechnology
Other


By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA


By Company
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried